1. Clinical Overview
A fixed-dose combination topical medication containing a potent corticosteroid (Betamethasone) and a broad-spectrum fluoroquinolone antibiotic (Ofloxacin). It is primarily used for the treatment of inflammatory dermatoses with secondary or suspected bacterial infections. The combination provides anti-inflammatory, immunosuppressive, anti-pruritic, and antibacterial actions.
| Onset | Duration | Bioavailability |
|---|---|---|
| Anti-inflammatory effects typically begin within 1-3 hours of application. Antibacterial effects commence upon contact with susceptible organisms. | Anti-inflammatory effects can last 12-24 hours post-application. The antibacterial effect is concentration-dependent and persists as long as therapeutic levels are maintained at the site. | Topical bioavailability is low and variable (<5% systemic absorption) on intact skin. Absorption increases significantly on inflamed, damaged, or occluded skin, and in areas with thin stratum corneum (e.g., face, groin). |
2. Mechanism of Action
Betamethasone exerts potent anti-inflammatory, immunosuppressive, vasoconstrictive, and anti-proliferative effects by binding to cytoplasmic glucocorticoid receptors, modulating gene transcription. Ofloxacin is a bactericidal antibiotic that inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, enzymes essential for DNA replication, transcription, repair, and recombination.
3. Indications & Uses
- Inflammatory dermatoses with secondary bacterial infection (e.g., infected eczema, infected contact dermatitis)
- Atopic dermatitis with suspected or confirmed bacterial superinfection
- Psoriasis (plaque type) with secondary infection
- Seborrheic dermatitis with infection
4. Dosage & Administration
Adult Dosage: Apply a thin film to the affected area 1 to 2 times daily. Frequency depends on severity; often initiated as twice daily and reduced to once daily as condition improves.
Administration: 1. Wash and dry hands and affected area gently. 2. Apply a thin layer and rub in gently until it disappears. 3. Do not cover with airtight occlusive dressings unless specifically directed by a physician. 4. Avoid contact with eyes, nostrils, mouth, and mucous membranes. 5. Wash hands after application unless hands are the treated area.
5. Side Effects
Common side effects may include:
- Local burning or stinging sensation at application site
- Itching (pruritus)
- Dryness of skin
- Erythema
- Skin irritation
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Other Topical Corticosteroids | Additive risk of local and systemic side effects (atrophy, HPA suppression). | Major |
| Systemic Corticosteroids (e.g., Prednisolone) | Increased risk of systemic corticosteroid adverse effects. | Moderate |
| Non-steroidal Anti-inflammatory Drugs (NSAIDs) topical/systemic | May increase risk of CNS stimulation and seizures (quinolone effect). | Moderate |
| Oral Anticoagulants (e.g., Warfarin) | Ofloxacin may potentiate anticoagulant effect; monitor INR if significant systemic absorption occurs. | Moderate |
| Theophylline | Ofloxacin may inhibit metabolism, increasing theophylline levels and toxicity risk. | Moderate |
| CYP3A4 Inhibitors (e.g., Ketoconazole, Itraconazole) | May increase systemic levels of Betamethasone if absorbed. | Minor |
7. Patient Counselling
- DO use exactly as prescribed by your doctor.
- DO wash hands before and after application (unless hands are treated).
- DO apply a thin film only; more is not better.
- DON'T use on open wounds, broken skin, or severe burns unless directed.
- DON'T cover the area with tight bandages or plastic wraps unless advised.
- DON'T use in or near the eyes. If contact occurs, rinse thoroughly with water.
- DON'T use for longer than the prescribed duration.
- DON'T share this medication with others.
8. Toxicology & Storage
Overdose: Topical overdose can manifest as: 1) Local: Severe skin atrophy, striae, telangiectasia, ulceration. 2) Systemic (from significant absorption): Cushingoid features (moon face, central obesity), hyperglycemia, hypertension, HPA axis suppression (weakness, fatigue), fluid and electrolyte disturbances. Ofloxacin systemic overdose could theoretically cause CNS stimulation, seizures, QT prolongation.
Storage: Store at room temperature (15-25°C), protected from light and moisture. Do not freeze. Keep the tube tightly closed. Keep out of reach and sight of children. Do not use after the expiry date printed on the packaging.